resazurin has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ippolito, JE; Piwnica-Worms, D | 1 |
| Chatzakos, V; Djureinovic, T; Helleday, T; Hunt, MC; Slätis, K | 1 |
| James, ND; Latham, JP; Mautner, V; Searle, PF | 1 |
3 other study(ies) available for resazurin and Cancer of Prostate
| Article | Year |
|---|---|
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
Topics: Adenocarcinoma; Atlases as Topic; Carcinoma, Neuroendocrine; Cell Line, Tumor; Enzyme Assays; Fluorescence; gamma-Aminobutyric Acid; Gene Expression Regulation, Neoplastic; Glucose; Glutamate Decarboxylase; Glutamate-Ammonia Ligase; Glutamine; Humans; Hydrogen-Ion Concentration; Male; Oxazines; Prostatic Neoplasms; Signal Transduction; Stress, Physiological; Survival Analysis; Xanthenes | 2014 |
N-acyl taurines are anti-proliferative in prostate cancer cells.
Topics: Adenocarcinoma; Apoptosis; Arachidonic Acids; Cannabinoid Receptor Modulators; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Male; Oxazines; Prostate; Prostatic Neoplasms; Taurine; Xanthenes | 2012 |
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Topics: Adenoviridae; Androgens; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Coloring Agents; Cytomegalovirus; Enhancer Elements, Genetic; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Jurkat Cells; Kinetics; Luciferases; Luminescent Proteins; Male; Oxazines; Polymerase Chain Reaction; Prodrugs; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Tissue Kallikreins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xanthenes | 2000 |